title: Macrocephaly and the control of brain growth in autistic disorders.
abstract: Autism is a childhood-onset neuropsychiatric disorder characterized by marked impairments in social interactions and communication, with restricted stereotypic and repetitive patterns of behavior, interests, and activities. Genetic epidemiology studies indicate that a strong genetic component exists to this disease, but these same studies also implicate significant environmental influence. The disorder also displays symptomatologic heterogeneity, with broad individual differences and severity on a graded continuum. In the search for phenotypes to resolve heterogeneity and better grasp autism's underlying biology, investigators have noted a statistical overrepresentation of macrocephaly, an indicator of enlarged brain volume. This feature is one of the most widely replicated biological findings in autism. What then does brain enlargement signify? One hypothesis invoked for the origin of macrocephaly is a reduction in neuronal pruning and consolidation of synapses during development resulting in an overabundance of neurites. An increase in generation of cells is an additional mechanism for macrocephaly, though it is less frequently discussed in the literature. Here, we review neurodevelopmental mechanisms regulating brain growth and highlight one underconsidered potential causal mechanism for autism and macrocephaly--an increase in neurogenesis and/or gliogenesis. We review factors known to control these processes with an emphasis on nuclear receptor activation as one signaling control that may be abnormal and contribute to increased brain volume in autistic disorders.
authors.affiliation: UMMS/EK Shriver Center, 200 Trapelo Road, Waltham, MA, USA. peter.mccaffery@umassmed.edu
authors.forename: Peter
authors.initials: P
authors.lastname: McCaffery
authors.forename: Curtis K
authors.initials: CK
authors.lastname: Deutsch
mesh_terms: D000222:Adaptation, Physiological; D000818:Animals; D001321:Autistic Disorder / Q000473:pathology* / Q000503:physiopathology*; D001921:Brain / Q000002:abnormalities / Q000254:growth & development* / Q000473:pathology*; D019465:Craniofacial Abnormalities / Q000473:pathology* / Q000503:physiopathology*; D006801:Humans; D008959:Models, Neurological; D018160:Receptors, Cytoplasmic and Nuclear / Q000378:metabolism*; D015398:Signal Transduction; D013577:Syndrome
chemical_list: D018160:Receptors, Cytoplasmic and Nuclear